Arkolith/Insider Trading/PRTK/Form 4

Brenner Randall B.

Chief Development & RegulatoryParatek Pharmaceuticals, Inc. (PRTK) · full profile →Form 4 · filed Aug 10, 2023
Net Selling
Open-Market Buys
$0
Open-Market Sells
$61K
Net Open-Market Flow
-$61K
Transactions
2
2 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Aug 9, 2023Sell(S)28K$2.20$61K415K
Aug 8, 2023Grant(A)68K—$0443K

Transaction Codes

S
Open-market sale
A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000904454-23-000478) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML